E-box


An E-box is a DNA response element found in some eukaryotes that acts as a protein-binding site and has been found to regulate gene expression in neurons, muscles, and other tissues. Its specific DNA sequence, CANNTG, with a palindromic canonical sequence of CACGTG, is recognized and bound by transcription factors to initiate gene transcription. Once the transcription factors bind to the promoters through the E-box, other enzymes can bind to the promoter and facilitate transcription from DNA to mRNA.

Discovery

The E-box was discovered in a collaboration between Susumu Tonegawa's and Walter Gilbert's laboratories in 1985 as a control element in immunoglobulin heavy-chain enhancer. They found that a region of 140 base pairs in the tissue-specific transcriptional enhancer element was sufficient for different levels of transcription enhancement in different tissues and sequences. They suggested that proteins made by specific tissues acted on these enhancers to activate sets of genes during cell differentiation.
In 1989, David Baltimore's lab discovered the first two E-box binding proteins, E12 and E47. These immunoglobulin enhancers could bind as heterodimers to proteins through bHLH domains. In 1990, another E-protein, ITF-2A was discovered that can bind to immunoglobulin light chain enhancers. Two years later, the third E-box binding protein, HEB, was discovered by screening a cDNA library from HeLa cells. A splice-variant of the E2-2 was discovered in 1997 and was found to inhibit the promoter of a muscle-specific gene.
Since then, researchers have established that the E-box affects gene transcription in several eukaryotes and found E-box binding factors that identify E-box consensus sequences. In particular, several experiments have shown that the E-box is an integral part of the transcription-translation feedback loop that comprises the circadian clock.

Binding

E-box binding proteins play a major role in regulating transcriptional activity. These proteins usually contain the basic helix-loop-helix protein structural motif, which allows them to bind as dimers. This motif consists of two amphipathic α-helices, separated by a small sequence of amino acids, that form one or more β-turns. The hydrophobic interactions between these α-helices stabilize dimerization. Besides, each bHLH monomer has a basic region, which helps mediate recognition between the bHLH monomer and the E-box. Depending on the DNA motif the bHLH protein has a different set of basic residues.
The E-box binding is modulated by Zn2+ in mice. The CT-Rich Regions located about 23 nucleotides upstream of the E-box is important in E-box binding, transactivation, and transcription of circadian genes BMAL1/NPAS2 and BMAL1/CLOCK complexes.
The binding specificity of different E-boxes is found to be essential in their function. E-boxes with different functions have a different number and type of binding factor.
The consensus sequence of the E-box is usually CANNTG; however, there exist other E-boxes of similar sequences called noncanonical E-boxes. These include, but are not limited to:
The link between E-box-regulated genes and the circadian clock was discovered in 1997, when Hao, Allen, and Hardin analyzed rhythmicity in the period gene in Drosophila melanogaster. They found a circadian transcriptional enhancer upstream of the per gene within a 69 bp DNA fragment. Depending upon PER protein levels, the enhancer drove high levels of mRNA transcription in both LD and DD conditions. The enhancer was found to be necessary for high-level gene expression but not for circadian rhythmicity. It also works independently as a target of the BMAL1/CLOCK complex.
The E-box plays an important role in circadian genes; so far, nine E/E'BOX controlled circadian genes have been identified: PER1, PER2, BHLHB2, BHLHB3, CRY1, DBP, Nr1d1, Nr1d2, and RORC. As the E-box is connected to several circadian genes, it is possible that the genes and proteins associated with it are "crucial and vulnerable points in the system."
The E-box is one of the top five transcription factor families associated with the circadian phase and is found in most tissues. A total of 320 E-box-controlled genes are found in the SCN, liver, aorta, adrenal, WAT, brain, atria, ventricle, prefrontal cortex, skeletal muscle, BAT, and calvarial bone.
E-box like CLOCK-related elements are also important in maintaining circadian rhythmicity in clock-controlled genes. Similarly to the E-box, the E-box like CLOCK related element can also induce transcription of BMAL1/CLOCK, which can then lead to expression in other EL-box containing genes. However, there are differences between the EL-box and the regular E-box. Suppressing DEC1 and DEC2 has a stronger effect on E-box than on EL-box. Furthermore, HES1, which can bind to a different consensus sequence, shows suppression effect in EL-box, but not in E-box.
Both non-canonical E-boxes and E-box-like sequences are crucial for circadian oscillation. Recent research on this forms an hypothesis that either a canonical or non-canonical E-box followed by an E-box like sequence with 6 base pair interval in between is a necessary combination for circadian transcription. In silico analysis also suggests that such an interval existed in other known clock-controlled genes.

Role of proteins which bind to E-boxes

There are several proteins that bind to the E-box and affect gene transcription.

CLOCK-ARNTL complex

The CLOCK-ARNTL complex is an integral part of the mammalian circadian cycle and vital in maintaining circadian rhythmicity.
Knowing that binding activates transcription of the per gene in the promoter region, researchers discovered in 2002 that DEC1 and DEC2 repressed the CLOCK-BMAL1 complex through direct interaction with BMAL1 and/or competition for E-box elements. They concluded that DEC1 and DEC2 were regulators of the mammalian molecular clock.
In 2006, Ripperger and Schibler discovered that the binding of this complex to the E-box drove circadian DBP transcription and chromatin transitions. It was concluded that CLOCK regulates DBP expression by binding to E-box motifs in enhancer regions located in the first and second introns.

MYC (c-Myc, an [oncogene])

MYC, a gene that codes for a transcription factor Myc, is important in regulating mammalian cell proliferation and apoptosis.
In 1991, researchers tested whether c-Myc could bind to DNA by dimerizing it to E12. Dimers of E6, the chimeric protein, were able to bind to an E-box element which was recognized by other HLH proteins. Expression of E6 suppressed the function of c-Myc, which showed a link between the two.
In 1996, it was found that Myc heterodimerizes with MAX and that this heterodimeric complex could bind to the CACTG E-box sequence and activate transcription.
In 1998, it was concluded that the function of c-Myc depends upon activating transcription of particular genes through E-box elements.

[MYOD1] (MyoD)

MyoD comes from the Mrf bHLH family and its main role is myogenesis, the formation of muscular tissue. Other members in this family include myogenin, Myf5, Myf6, Mist1, and Nex-1.
When MyoD binds to the E-box motif CANNTG, muscle differentiation and expression of muscle-specific proteins is initiated. The researchers ablated various parts of the recombinant MyoD sequence and concluded that MyoD used encompassing elements to bind the E-box and the tetralplex structure of the promoter sequence of the muscle specific gene α7 integrin and sarcomeric sMtCK.
MyoD regulates HB-EGF, a member of the EGF family that stimulates cell growth and proliferation. It plays a role in the development of hepatocellular carcinoma, prostate cancer, breast cancer, esophageal cancer, and gastric cancer.
MyoD can also bind to noncanonical E boxes of MyoG and regulate its expression.

MyoG (Myogenin)

MyoG belongs to the MyoD transcription factor family. MyoG-E-Box binding is necessary for neuromuscular synapse formation as an HDAC-Dach2-myogenin signaling pathway in skeletal muscle gene expression has been identified. Decreased MyoG expression has been shown in patients with muscle wasting symptom.
MyoG and MyoD have also been shown to involve in myoblast differentiation. They act by transactivating cathepsin B promotor activity and inducing its mRNA expression.

TCF3 (E47)

E47 is produced by alternative spliced E2A in E47 specific bHLH-encoding exons. Its role is to regulate tissue specific gene expression and differentiation. Many kinases have been associated with E47 including 3pk and MK2. These 2 proteins form a complex with E47 and reduce its transcription activity. CKII and PKA are also shown to phosphorylate E47 in vitro.
Similar to other E-box binding proteins, E47 also binds to the CANNTG sequence in the E-box. In homozygous E2A knock-out mice, B cells development stops before the DJ arrangement stage and the B cells fail to mature. E47 has been shown to bind either as heterodimer or as homodimer.

Recent research

Although the structural basis for how BMAL1/CLOCK interact with the E-box is unknown, recent research has shown that the bHLH protein domains of BMAL1/CLOCK are highly similar to other bHLH containing proteins, e.g. Myc/Max, which have been crystallized with E-boxes. It is surmised that specific bases are necessary to support this high affinity binding. Furthermore, the sequence constraints on the region around the circadian E-box are not fully understood: it is believed to be necessary but not sufficient for E-boxes to be randomly spaced from each other in the genetic sequence in order for circadian transcription to occur. Recent research involving the E-box has been aimed at trying to find more binding proteins as well as discovering more mechanisms for inhibiting binding.
Researchers at the Medical School of Nanjing University found that the amplitude of FBXL3 is expressed via an E-box. They studied mice with FBXL3 deficiency and found that it regulates feedback loops in circadian rhythms by affecting circadian period length.
A study published April 4, 2013 by researchers at Harvard Medical School found that the nucleotides on either side of an E-box influences which transcription factors can bind to the E-box itself. These nucleotides determine the 3-D spatial arrangement of the DNA strand and restrict the size of binding transcription factors. The study also found differences in binding patterns between in vivo and in vitro strands.